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Vitamin D deﬁciency has been implicated in chronic pain. Immigrant and ethnic minority populations have been shown to have
lower vitamin D levels than native Western populations and often to be vitamin D deﬁcient. This systematic review investigates the
relationship between vitamin D and chronic pain in immigrant and ethnic minority populations. Included were studies reporting
on 25-OH vitamin D levels in immigrant/ethnic minority populations aﬀected by chronic pain, and/or reporting on the treatment
of chronic pain with vitamin D preparations in such populations. We found that 25-OH vitamin D levels were low and often
deﬁcient in immigrant/ethnic minority populations. Vitamin D levels depended on the latitude of the study location and hence
sunlight exposure. There was insuﬃcient evidence to reach a verdict on the value of treating chronic pain in immigrant/ethnic
minority patients with vitamin D preparations because the studies were few, small, and of low quality.
1.Introduction
Chronic pain is among the many conditions that have
recently been associated with vitamin D deﬁciency [1]. A
number of studies have suggested a link between low levels
of vitamin D and higher incidence of chronic pain [2–4].
Furthermore, indirect evidence that vitamin D levels are
important in pain is provided by the association of latitude
and season of the year with pain [5–7]. We have recently
published a systematic review on the role of vitamin D in
chronic pain [8]. It concluded that the evidence did not,
on balance, support the hypothesis that 25-OH vitamin D
deﬁciency played a role in chronic painful conditions nor
that vitamin D supplementation is a useful treatment for
chronic pain.
It is suggested that immigrants and members of ethnic
minorities are especially at risk of 25-OH vitamin D
deﬁciency due to darker skin color, low sun exposure, diet,
andtraditionaldress(veiledwomen,forexample).Anumber
of studies show that such populations have lower vitamin D
levels and higher prevalence of vitamin D deﬁciency than
native Western populations [9–12]. Other work suggests
that there is an excess of widespread pain in immigrant
communities along with lower levels of vitamin D [13,
14] and that low levels of vitamin D in ethnic minority
populations correlate with musculoskeletal pain [15].
Vitamin D and its roles in health and disease have
recently received great interest both in the scientiﬁc com-
munity [1] and in the popular press [16]. Many tissues
express vitamin D receptors and it is not surprising that
a physiological role for vitamin D has been proposed in a
number of organs and organ systems, not limited to the
skeleton. Vitamin D deﬁciency likewise has been implicated
in a number of diseases ranging from autoimmune disease
and diabetes to cardiovascular disease, various cancers, and
chronic pain [1]. A meta-analysis even suggested reduced
all-cause-mortality with vitamin D supplementation [17].
This stands in contrast to the antioxidant vitamins A and2 International Journal of Endocrinology
E, where widespread supplementation has been questioned
after a review suggested a possible increase in mortality rates
[18].
Some experts advocate limited and sensible sun exposure
and vitamin D supplementation [1] in order to ensure
adequate blood levels of 25-OH vitamin D. Excessive dietary
supplementation can lead to vitamin D intoxication [19],
and excessive sun exposure increases the risk of skin
cancers. Skin cancers are a signiﬁcant health problem and,
although cases of vitamin D intoxication have been reported
only infrequently, they could become more common with
widespread use of vitamin D supplements. Before the use of
vitamin D supplements can be advocated, the evidence for
health beneﬁts and harm needs to be assessed rigorously in
each of the proposed areas of beneﬁt.
If there were a link between 25-OH vitamin D deﬁciency
and chronic pain, one might expect to ﬁnd an inverse
association between pain and 25-OH vitamin D levels
and a demonstrable beneﬁt of vitamin D supplementation
with regard to pain outcomes in interventional studies.
Our previous systematic review [8] did not support either
hypothesis for the overall population. As immigrants and
members of ethnic minorities are more severely aﬀected
by 25-OH vitamin D deﬁciency, and where any association
between vitamin D and chronic pain should be stronger,
it is important to re-examine the issue in this particular
population subgroup.
2.MaterialandMethods
We searched Medline (PubMed) using various search
terms for vitamin D (vitamin D; vitamin D2; vitamin
D3; 1-alpha hydroxyvitamin D3; 1-alpha hydroxycalciferol;
1,25-dihydroxyvitaminD3;1,25-dihydroxycholecalciferol;25
hydroxycholecalciferol; 25-hydroxyvitamin D; alfacalcidol;
calcidiol; calcitriol; calcifediol; calciferol; ergocalciferol;
cholecalciferol; and spelling variations thereof) and “pain∗.”
The last search was conducted on February 9, 2009. The
limits in PubMed were set to “humans.” Because electronic
searchingcommonlydoesnotrevealallrelevantstudies(par-
ticularlyobservational studies),we alsosearched throughthe
references of retrieved articles and relevant review articles
for additional publications. We sought reports of any kind
of clinical study published in any language and included
all studies that reported on ethnic minority or immigrant
populations with chronic pain conditions.
For inclusion in this review studies needed to be
conducted in ethnic minority or immigrant subjects with
chronicpain,togivemeanvaluesfor25-OHvitaminDlevels
in these populations, and/or to investigate pain outcomes
after vitamin D supplementation. We accepted any dose
and regimen of vitamin D supplementation. We included
only full publications (no abstracts). We did not include
individual case reports. Vitamin D requirements diﬀer in
children and adults so that a comparison of vitamin D levels
between populations of children and adults would not be
instructive. We, therefore, restricted the scope of this review
to studies in adult populations. For comparison, with the
general Western populations, we took data from our recent
systematic review [8].
We deliberately deﬁned chronic pain in the broadest
possible sense and accepted any kind of vitamin D therapy
in order to be inclusive and uncover any association.
Osteomalacia can result from vitamin D deﬁciency in adults,
and manifest as musculoskeletal pain. The link between
vitamin D deﬁciency and pain in osteomalacia is well estab-
lished, and in frank osteomalacia, the case may be obvious.
There is the possibility that “subclinical” osteomalacia might
manifest as musculoskeletal pain. In fact, there might well
be a spectrum, from hypovitaminosis D, through to frank
osteomalacia, with subclinical osteomalacia manifesting as
musculoskeletal pain in some individuals. On the other
hand, vitamin D deﬁciency might potentially cause chronic
pain by some other mechanism and changes in markers of
bone metabolism might be coincidental. We did not exclude
studies of patients with osteomalacia; but in order to be
included in this review, all subjects in the study population
needed to have chronic pain.
We extracted information about study design, study
location, condition and population, patient characteristics,
mean 25-OH vitamin D levels, types and doses of vitamin
D preparations used, study duration, pain outcomes, and
adverse events. We extracted information for patients in
“pain” and healthy “control” groups when their 25-OH
vitamin D levels were reported, or when they were treated
with vitamin D preparations. Where possible, we also did
this for nonimmigrant populations in the same study, for
the sake of comparison with immigrant/ethnic minority
patients. Guidelines for quality of reporting of meta-analyses
were followed where appropriate [20].
3. Results
We identiﬁed seven relevant studies; details are in Table 1.
There were no randomised controlled trials. Only two small
studies investigated treatment with vitamin D [21, 22]; both
were case series. Five studies were purely observational with
no intervention [3, 23–26]. The total number of immigrant
or ethnic minority patients in “pain” and “control” groups
was 431. Six of the seven studies were of musculoskeletal
pain; another one [26] included subjects with any kind of
chronic persistent pain.
The two case series investigating treatment with vitamin
D[ 21, 22] together had 17 patients. De Torrent´ ed el aJ a r a
et al. [22] stated that for most of their patients treatment
consisted of intramuscular injections of 300000IU of chole-
calciferol at monthly intervals and an ongoing course of
oral calcium (1000mg) and cholecalciferol (20µg). Nellen
et al. [21] did not specify treatment details other than that
it consisted of vitamin D and calcium. All 17 patients were
reported to improve with vitamin D treatment. According to
De Torrent´ ed el aJ a r ae ta l .[ 22] symptoms (musculoskeletal
pain) disappeared within three months in 10/11 patients and
within seven months in all. Nellen et al. [21] found that all
of their patients became symptom free within three months.
Neither study used validated scales for the assessment of pain
or commented on adverse events.International Journal of Endocrinology 3
Table 1: Characteristics of included studies.
Reference Study type Location Condition Study
population
Numbers of
immigrant/
ethnic minority
patients with
painful
conditions and
data on vitamin
Dl e v e l s
Mean 25-OH
vitamin D
(ng/mL) in
immigrant/
ethnic minority
patients
Outcome of
vitamin D
treatment
Lowenthal
and Shany
1994 [23]
Case series Beer Sheva,
Israel
Osteomalacia
(with bone pain)
Bedouin Arab
women (an
ethnic minority
in Israel)
12 4.1
Nellen et al.
1996 [21] Case series Amsterdam,
Netherlands
Hypovitaminosis
Do s t e o p a t h y( w i t h
musculoskeletal
pain)
Immigrant
women 68 . 1
Symptoms
resolved in all
patients
Plotnikoﬀ
and Quigley
2003 [24]
Cross-
sectional
study
Minneapolis,
Minnesota, USA
Musculoskeletal
pain
Immigrant and
nonimmigrant
patients
83 12.4
De Torrent´ ed e
la Jara et al.
2004 [22]
Case series Lausanne,
Switzerland
Hypovitaminosis
D( w i t h
musculoskeletal
pain)
Female asylum
seekers 11 4.4
Pain
disappeared in
10/11 within
three months
and in all
patients within
seven months
Benson et al.
2006 [3]
Case-control
study
Adelaide,
Australia Muscle pain Australian
Aborigines 8 16.4
Helliwell et al.
2006 [25]
Case-control
study Leeds, UK Musculoskeletal
pain
Patients of
South Asian
ethnicity
127 6.9
Bartley 2008
[26]
Cross-
sectional
study
Auckland, New
Zealand Chronic pain
Ethnic minority
and European
ethnicity
patients
58 21.2
All but one noninterventional study [26]r e p o r t e dm e a n
25-OH vitamin D levels in subjects with chronic pain in
the deﬁciency range below 20ng/mL [1]. One study [3]
found lower levels of 25-OH vitamin D in eight Australian
Aborigines aﬀected by chronic pain than in eight Aboriginal
controls. Another in the UK [25] found similar 25-OH
vitamin D levels in 127 South Asians aﬀected by chronic
widespread pain as in South Asians diagnosed with speciﬁc
rheumatic diseases. A comparison of 83 immigrants with
musculoskeletal pain in Minnesota with 67 nonimmigrants
with musculoskeletal pain found slightly higher levels of
25-OH vitamin D in the immigrants [24], though both
“immigrant” and “nonimmigrant” populations were ethni-
cally diverse.
Figure 1 compares 25-OH vitamin D levels in immi-
grants and ethnic minority populations from this review
with data from our recent review on 25-OH vitamin D levels
inthe generalpopulation [8].Overall,wefoundtheexpected
dependence of 25-OH vitamin D level on latitude of study
location (sunlight) and lower levels of 25-OH vitamin D in
immigrant/ethnic minority populations with chronic pain
compared with patients from the general population with
chronic pain.
4. Discussion
On the one hand, there is a considerable evidence that 25-
OH vitamin D levels are lower in immigrant and ethnic
minority than in native Western populations [9–12], and
circumstantial evidence that low levels of 25-OH vitamin D
are implicated in chronic pain [1–8, 27, 28]. On the other
hand, this systematic review uncovered very little evidence
comparing average levels of 25-OH vitamin D between
“pain”and“control”patientsfromimmigrant/ethnicminor-
ity populations or investigating treatment with vitamin D
for chronic pain in such populations. Despite using a broad
inclusive search strategy, there was a dearth of evidence.
What little evidence we found was of low quality. There
werenorandomisedcontrolledtrials.Treatmentstudieswere
too small and reported insuﬃcient detail on the vitamin
D preparations used and on outcome measures to allow
meaningful conclusions to be drawn.4 International Journal of Endocrinology
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Figure 1: 25-OH vitamin D levels in pain subjects and nonpain
controls according to latitude (northern or southern hemisphere).
White circles indicate pain subjects from the general Western
population; black circles indicate nonpain (control) subjects from
the general population. Red circles show data for pain subjects from
immigrant/ethnic minority populations and the blue circle is from
an ethnic minority nonpain control population. The size of the
symbol is proportional to the size of the study populations (inset
logarithmic scale).
All but one study found average levels 25-OH vitamin
D to be deﬁcient. In isolation, this is hard to interpret. The
only study [24] comparing immigrants with nonimmigrants
did so in a way that both “immigrant” and “nonimmigrant”
groups were ethnically diverse. South Asians in the UK
with chronic widespread pain had similar vitamin D levels
to South Asians with speciﬁc rheumatic diseases [25].
Subjects with speciﬁc rheumatic diseases, however, are an
inappropriate control for the question of this review because
some of them may well have had chronic pain (which is
why data from this group are not included as “controls” in
Figure 1).Theonlystudycomparing25-OHvitaminDlevels
in an ethnic minority group with chronic pain with controls
fromthesameethnicminority[3]didﬁndlowerlevelsof25-
OH vitamin D in the subjects with pain. However, this study
was too small, with 16 subjects, to allow any meaningful
interpretation.
Comparing immigrant/ethnic minority populations and
general Western populations with chronic pain, we found
lower levels of 25-OH vitamin D in immigrant/ethnic
minority populations, sometimes very low (Figure 1). This
is, however, similar to what is found in populations without
chronic pain. Immigrants tend to have lower 25-OH vitamin
D levels than nonimmigrants, regardless of whether they
suﬀer from chronic painful conditions. This might indicate
independence of 25-OH vitamin D levels from chronic
pain; but this is only speculation because the amount of
informationissosmall,andstudieswereinconsistentinwhat
they measured and reported.
5. Conclusions
T h e r ei si n s u ﬃcient evidence of high quality to conﬁrm
a link between 25-OH vitamin D levels and chronic pain
in immigrant and ethnic minority populations. Absence of
evidence is not an evidence of absence, and we cannot
conclude that vitamin D is not associated with chronic
pain, though we can begin to question the strength of any
association. The subject is important because vitamin D
deﬁciency is common, and commonly severe in immigrants,
and treatment—if indicated—would be easy and cheap.
Therefore, the question addressed in this review demands
further studies, better studies, and better reporting of study
results. We are not alone in thinking that more and better
studies on the eﬀect of vitamin D in chronic pain are needed
[28]. What we need are large double-blind randomized
controlled trials, conducted in diﬀerent painful conditions,
stratiﬁed by baseline 25-OH vitamin D level, with deﬁned
interventions and ideally with outcome stratiﬁed by post-
treatment 25-OH vitamin D level. Given the limited level
of knowledge, a placebo group would be necessary to
demonstrate causation and eﬀect; 25-OH vitamin D levels
ought to be monitored. These randomized controlled trials
would need standardized, validated pain outcomes (such as
the number of patients achieving at least 50% pain relief),
andforanassessmentofbeneﬁtversusharmwouldalsoneed
to report on adverse events.
Acknowledgments
Pain Research is supported in part by the Oxford Pain
Research Trust, which had no role in design, planning,
execution of the study, or in writing the manuscript. R.
A. Moore is funded by NIHR Biomedical Research Centre
Programme.
References
[1] M. F. Holick, “Vitamin D deﬁciency,” New England Journal of
Medicine, vol. 357, no. 3, pp. 266–281, 2007.
[2] K.Atherton,D.J.Berry,T.Parsons,G.J.Macfarlane,C.Power,
a n dE .H y p p ¨ onen, “Vitamin D and chronic widespread pain
in a white middle-aged British population: evidence from a
cross-sectional population survey,” Annals of the Rheumatic
Diseases, vol. 68, no. 6, pp. 817–822, 2009.
[3] J. Benson, A. Wilson, N. Stocks, and N. Moulding, “Muscle
pain as an indicator of vitamin D deﬁciency in an urban Aus-
tralian Aboriginal population,” Medical Journal of Australia,
vol. 185, no. 2, pp. 76–77, 2006.
[4] A. Lotﬁ, A. M. Abdel-Nasser, A. Hamdy, A. A. Omran, and
M. A. El-Rehany, “Hypovitaminosis D in female patients with
chronic low back pain,” Clinical Rheumatology, vol. 26, no. 11,
pp. 1895–1901, 2007.
[5] D. D. Mitsikostas, D. Tsaklakidou, N. Athanasiadis, and A.
Thomas, “The prevalence of headache in Greece: correlations
to latitude and climatological factors,” Headache, vol. 36, no.
3, pp. 168–173, 1996.International Journal of Endocrinology 5
[6] M. Saps, C. Blank, S. Khan, et al., “Seasonal variation in
the presentation of abdominal pain,” Journal of Pediatric
Gastroenterology and Nutrition, vol. 46, no. 3, pp. 279–284,
2008.
[ 7 ] Q .Y .Z e n g ,R .C h e n ,Z .Y .X i a o ,e ta l . ,“ L o wp r e v a l e n c eo fk n e e
and back pain in southeast China; the Shantou COPCORD
study,”JournalofRheumatology,vol.31,no.12,pp.2439–2443,
2004.
[ 8 ] S .S t r a u b e ,R .A .M o o r e ,S .D e rry ,a n dH .J .M c Q u a y ,“ V i t a m i n
D and chronic pain,” Pain, vol. 141, no. 1-2, pp. 10–13, 2009.
[9] H. Glerup, K. Mikkelsen, L. Poulsen, et al., “Hypovitaminosis
D myopathy without biochemical signs of osteomalacic bone
involvement,” Calciﬁed Tissue International,v o l .6 6 ,n o .6 ,p p .
419–424, 2000.
[10] I. Grootjans-Geerts and J. P. M. Wielders, “A pilot study
of hypovitaminosis D in apparently healthy, veiled, Turkish
women: 82% had severe vitamin D deﬁciency,” Nederlands
Tijdschrift voor Geneeskunde, vol. 146, no. 23, pp. 1100–1101,
2002.
[11] K.Holvik,H.E.Meyer,E.Haug,andL.Brunvand,“Prevalence
and predictors of vitamin D deﬁciency in ﬁve immigrant
groups living in Oslo, Norway: the Oslo Immigrant Health
Study,” European Journal of Clinical Nutrition,v o l .5 9 ,n o .1 ,
pp. 57–63, 2005.
[ 1 2 ] J .M yt t o n ,A .P .F r a t e r ,G .O a k l e y ,E .M u rp h y ,M .J .B a rb e r ,a n d
S. Jahfar, “Vitamin D deﬁciency in multicultural primary care:
acaseseriesof299patients, ”BritishJournalofGeneralPractice,
vol. 57, no. 540, pp. 577–579, 2007.
[13] E. Serhan, P. Newton, H. A. Ali, S. Walford, and B. M. Singh,
“Prevalence of hypovitaminosis D in Indo-Asian patients
attending a rheumatology clinic,” Bone, vol. 25, no. 5, pp. 609–
611, 1999.
[14] G. J. Macfarlane, B. Palmer, D. Roy, C. Afzal, A. J. Silman,
a n dT .O ’ N e i l l ,“ A ne x c e s so fw i d e s p r e a dp a i na m o n gS o u t h
Asians: are low levels of vitamin D implicated?” Annals of the
Rheumatic Diseases, vol. 64, no. 8, pp. 1217–1219, 2005.
[15] M. Z. Erkal, J. Wilde, Y. Bilgin, et al., “High prevalence of
vitamin D deﬁciency, secondary hyperparathyroidism and
generalized bone pain in Turkish immigrants in Germany:
identiﬁcation of risk factors,” Osteoporosis International, vol.
17, no. 8, pp. 1133–1140, 2006.
[16] J. Laurance, “The virtues of Vitamin D: it’s time we saw
the light,” The Independent, September 2007, http://www
.independent.co.uk/life-style/health-and-families/health-
news/the-virtues-of-vitamin-d-its-time-we-saw-the-light-
402749.html.
[17] P. Autier and S. Gandini, “Vitamin D supplementation and
total mortality: a meta-analysis of randomized controlled
trials,”ArchivesofInternalMedicine,vol.167,no.16,pp.1730–
1737, 2007.
[18] G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti,
and C. Gluud, “Antioxidant supplements for prevention of
mortality in healthy participants and patients with various
diseases,” Cochrane Database of Systematic Reviews,n o .2 ,
Article ID CD007176, 2008.
[19] J. S. Adams and G. Lee, “Gains in bone mineral density
with resolution of vitamin D intoxication,” Annals of Internal
Medicine, vol. 127, no. 3, pp. 203–206, 1997.
[20] D. Moher, D. J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.
F. Stroup, “Improving the quality of reports of meta-analyses
of randomised controlled trials: the QUOROM statement,”
Lancet, vol. 354, no. 9193, pp. 1896–1900, 1999.
[21] J.F.Nellen,Y.M.Smulders,P.H.JosFrissen,E.H.Slaats,andJ.
Silberbusch, “Hypovitaminosis D in immigrant women: slow
to be diagnosed,” British Medical Journal, vol. 312, no. 7030,
pp. 570–572, 1996.
[22] G. De Torrent´ ed el aJ a r a ,A .P ´ ecoud, and B. Favrat, “Muscu-
loskeletal pain in female asylum seekers and hypovitaminosis
D3,” British Medical Journal, vol. 329, no. 7458, pp. 156–157,
2004.
[23] M. N. Lowenthal and S. Shany, “Osteomalacia in Bedouin
women of the Negev,” Israel Journal of Medical Sciences, vol.
30, no. 7, pp. 520–523, 1994.
[24] G. A. Plotnikoﬀ and J. M. Quigley, “Prevalence of severe
hypovitaminosis D in patients with persistent, nonspeciﬁc
musculoskeletalpain,”MayoClinicProceedings,vol.78,no.12,
pp. 1463–1470, 2003.
[ 2 5 ]P .S .H e l l i w e l ,G .H .I b r a h i m ,Z .K a r i m ,K .S o k o l l ,a n dH .
Johnson, “Unexplained musculoskeletal pain in people of
South Asian ethnic group referred to a rheumatology clinic-
relationship to biochemical osteomalacia, persistence over
time and response to treatment with calcium and vitamin D,”
Clinical and Experimental Rheumatology, vol. 24, no. 4, pp.
424–427, 2006.
[26] J. Bartley, “Prevalence of vitamin D deﬁciency among
patients attending a multidisciplinary tertiary pain clinic,”
New Zealand Medical Journal, vol. 121, no. 1286, pp. 57–62,
2008.
[27] H. Badsha, M. Daher, and K. Ooi Kong, “Myalgias or non-
speciﬁc muscle pain in Arab or Indo-Pakistani patients may
indicate vitamin D deﬁciency,” Clinical Rheumatology, vol. 28,
no. 8, pp. 971–973, 2009.
[28] G. Schwalfenberg, “Improvement of chronic back pain or
failed back surgery with vitamin D repletion: a case series,”
Journal of the American Board of Family Medicine, vol. 22, no.
1, pp. 69–74, 2009.